BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 26826926)

  • 1. Generation and validation of PAX7 reporter lines from human iPS cells using CRISPR/Cas9 technology.
    Wu J; Hunt SD; Xue H; Liu Y; Darabi R
    Stem Cell Res; 2016 Mar; 16(2):220-8. PubMed ID: 26826926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation and Characterization of a MYF5 Reporter Human iPS Cell Line Using CRISPR/Cas9 Mediated Homologous Recombination.
    Wu J; Hunt SD; Xue H; Liu Y; Darabi R
    Sci Rep; 2016 Jan; 6():18759. PubMed ID: 26729410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human Induced Pluripotent Stem Cell NEUROG2 Dual Knockin Reporter Lines Generated by the CRISPR/Cas9 System.
    Li S; Xue H; Wu J; Rao MS; Kim DH; Deng W; Liu Y
    Stem Cells Dev; 2015 Dec; 24(24):2925-42. PubMed ID: 26414932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myogenic Progenitor Cell Lineage Specification by CRISPR/Cas9-Based Transcriptional Activators.
    Kwon JB; Vankara A; Ettyreddy AR; Bohning JD; Gersbach CA
    Stem Cell Reports; 2020 May; 14(5):755-769. PubMed ID: 32330446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of PAX7 Reporter Cells to Investigate Skeletal Myogenesis from Human Pluripotent Stem Cells.
    Xi H; Young CS; Pyle AD
    STAR Protoc; 2020 Dec; 1(3):100158. PubMed ID: 33377052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient CRISPR-Cas9-mediated generation of knockin human pluripotent stem cells lacking undesired mutations at the targeted locus.
    Merkle FT; Neuhausser WM; Santos D; Valen E; Gagnon JA; Maas K; Sandoe J; Schier AF; Eggan K
    Cell Rep; 2015 May; 11(6):875-883. PubMed ID: 25937281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiation of the human PAX7-positive myogenic precursors/satellite cell lineage
    Al Tanoury Z; Rao J; Tassy O; Gobert B; Gapon S; Garnier JM; Wagner E; Hick A; Hall A; Gussoni E; Pourquié O
    Development; 2020 Jun; 147(12):. PubMed ID: 32541004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Derivation of Skeletal Myogenic Precursors from Human Pluripotent Stem Cells Using Conditional Expression of PAX7.
    Darabi R; Perlingeiro RC
    Methods Mol Biol; 2016; 1357():423-39. PubMed ID: 25403466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient genomic correction methods in human iPS cells using CRISPR-Cas9 system.
    Li HL; Gee P; Ishida K; Hotta A
    Methods; 2016 May; 101():27-35. PubMed ID: 26525194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Both TALENs and CRISPR/Cas9 directly target the HBB IVS2-654 (C > T) mutation in β-thalassemia-derived iPSCs.
    Xu P; Tong Y; Liu XZ; Wang TT; Cheng L; Wang BY; Lv X; Huang Y; Liu DP
    Sci Rep; 2015 Jul; 5():12065. PubMed ID: 26156589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient generation of hiPSC neural lineage specific knockin reporters using the CRISPR/Cas9 and Cas9 double nickase system.
    Li S; Xue H; Long B; Sun L; Truong T; Liu Y
    J Vis Exp; 2015 May; (99):e52539. PubMed ID: 26065872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluorescent labeling and visualization of human induced pluripotent stem cells with the use of transcription activator-like effector nucleases.
    Sekine K; Takebe T; Taniguchi H
    Transplant Proc; 2014 May; 46(4):1205-7. PubMed ID: 24815161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An efficient method to enrich for knock-out and knock-in cellular clones using the CRISPR/Cas9 system.
    Niccheri F; Pecori R; Conticello SG
    Cell Mol Life Sci; 2017 Sep; 74(18):3413-3423. PubMed ID: 28421278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPR/Cas-mediated knock-in via non-homologous end-joining in the crustacean Daphnia magna.
    Kumagai H; Nakanishi T; Matsuura T; Kato Y; Watanabe H
    PLoS One; 2017; 12(10):e0186112. PubMed ID: 29045453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of Knock-In Pigs Carrying Oct4-tdTomato Reporter through CRISPR/Cas9-Mediated Genome Engineering.
    Lai S; Wei S; Zhao B; Ouyang Z; Zhang Q; Fan N; Liu Z; Zhao Y; Yan Q; Zhou X; Li L; Xin J; Zeng Y; Lai L; Zou Q
    PLoS One; 2016; 11(1):e0146562. PubMed ID: 26756580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homology arms of targeting vectors for gene insertions and CRISPR/Cas9 technology: size does not matter; quality control of targeted clones does.
    Petrezselyova S; Kinsky S; Truban D; Sedlacek R; Burtscher I; Lickert H
    Cell Mol Biol Lett; 2015 Dec; 20(5):773-87. PubMed ID: 26540224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR/Cas9 mediated GFP-human dentin matrix protein 1 (DMP1) promoter knock-in at the ROSA26 locus in mesenchymal stem cell for monitoring osteoblast differentiation.
    Shahabipour F; Oskuee RK; Shokrgozar MA; Naderi-Meshkin H; Goshayeshi L; Bonakdar S
    J Gene Med; 2020 Dec; 22(12):e3288. PubMed ID: 33047833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Highly efficient biallelic genome editing of human ES/iPS cells using a CRISPR/Cas9 or TALEN system.
    Takayama K; Igai K; Hagihara Y; Hashimoto R; Hanawa M; Sakuma T; Tachibana M; Sakurai F; Yamamoto T; Mizuguchi H
    Nucleic Acids Res; 2017 May; 45(9):5198-5207. PubMed ID: 28334759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variable expression and silencing of CRISPR-Cas9 targeted transgenes identifies the
    Bhagwan JR; Collins E; Mosqueira D; Bakar M; Johnson BB; Thompson A; Smith JGW; Denning C
    F1000Res; 2019; 8():1911. PubMed ID: 32789000
    [No Abstract]   [Full Text] [Related]  

  • 20. Generation of a heterozygous knockout human embryonic stem cell line for the OCIAD1 locus using CRISPR/CAS9 mediated targeting: BJNhem20-OCIAD1-CRISPR-39.
    Shetty DK; Inamdar MS
    Stem Cell Res; 2016 Mar; 16(2):308-10. PubMed ID: 27345991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.